[Treatment of thyroid ophthalmopathy--a clinical case].
Thyroid ophthalmopathy is a relatively frequent pathology. Usually it is a self-limited affection but same cases develop visual-threatening complication. The management of thyroid disorders necessitates both treatment of the systemic thyroid disease and management of the thyroid eye disease in order to alleviate the ocular discomfort, to prevent disfigurement and to avoid the visual threatening complications.
Andrei
Sorana
S
Spitalul Clinic de UrgentA Militar Central.
Zemba
M
M
Zugravu
Viorica
V
Enache
Veronica
V
Renetti
A
A
Spiroiu
Cristina
C
D016572:Cyclosporine / Q000627:therapeutic use; D003937:Diagnosis, Differential; D004359:Drug Therapy, Combination; D005938:Glucocorticoids / Q000627:therapeutic use; D049970:Graves Ophthalmopathy / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use; D008775:Methylprednisolone / Q000627:therapeutic use; D008875:Middle Aged; D009530:Nicergoline / Q000627:therapeutic use; D009901:Optic Nerve Diseases / Q000209:etiology; D012307:Risk Factors; D012907:Smoking / Q000009:adverse effects; D016896:Treatment Outcome; D014665:Vasodilator Agents / Q000627:therapeutic use; D058609:Visual Field Tests; D014803:Vitamin B Complex / Q000627:therapeutic use
D005938:Glucocorticoids; D007166:Immunosuppressive Agents; D014665:Vasodilator Agents; D014803:Vitamin B Complex; D016572:Cyclosporine; D009530:Nicergoline; D008775:Methylprednisolone; D008727:Methotrexate